FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Olav Dahl

Research Profile

Disorders

Procedures

Living Beings

Geographic Areas

Norway

Concepts & Ideas

Anatomy

Rectum

Chemicals & Drugs

Co-author Network

Publications

TOP 3
Anne Gry Bentzen; Olav Dahl; Gunilla Frykholm; Eva Hoff Wanderås; Tom Wilsgaard; Lise Balteskard; Marianne Grønlie Guren
Impaired health-related quality of life after chemoradiotherapy for anal cancer: late effects in a national cohort of 128 survivors.
Marianne Brydøy; Olav Dahl; Sophie D Fosså; O Klepp; Tore Wentzel-Larsen; E A Wist; T Bjøro; Roy M Bremnes
Sperm counts and endocrinological markers of spermatogenesis in long-term survivors of testicular cancer.
M P Myklebust; H E Myrvold; R G Pestell; H Rui; T H Tran; Kjell Magne Tveit; B Vonen; O Fluge; H Elsaleh; E S Knudsen; Sabine Leh; Z Li; Olav Dahl
Expression of cyclin D1a and D1b as predictive factors for treatment response in colorectal cancer.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Olav Dahl (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Anne Gry Bentzen; Olav Dahl; Gunilla Frykholm; Eva Hoff Wanderås; Tom Wilsgaard; Lise Balteskard; Marianne Grønlie Guren
Impaired health-related quality of life after chemoradiotherapy for anal cancer: late effects in a national cohort of 128 survivors.
Acta oncologica (Stockholm, Sweden) 2013;52(4):736-44.
2012: Marianne Brydøy; Olav Dahl; Sophie D Fosså; O Klepp; Tore Wentzel-Larsen; E A Wist; T Bjøro; Roy M Bremnes
Sperm counts and endocrinological markers of spermatogenesis in long-term survivors of testicular cancer.
British journal of cancer 2012;107(11):1833-9.
2012: M P Myklebust; H E Myrvold; R G Pestell; H Rui; T H Tran; Kjell Magne Tveit; B Vonen; O Fluge; H Elsaleh; E S Knudsen; Sabine Leh; Z Li; Olav Dahl
Expression of cyclin D1a and D1b as predictive factors for treatment response in colorectal cancer.
British journal of cancer 2012;107(10):1684-91.
2012: Anne Gry Bentzen; Olav Dahl; Gunilla Frykholm; Marianne Grønlie Guren; Kjell M Tveit; Eva H Wanderås; Tom Wilsgaard; Lise Balteskard
Chemoradiotherapy of anal carcinoma: survival and recurrence in an unselected national cohort.
International journal of radiation oncology, biology, physics 2012;83(2):e173-80.
2012: Kjell Magne Tveit; Mette Karen Yilmaz; Elke Birkemeyer; Olav Dahl; Olav F Dajani; Anne Berit Erdal; Tone Fokstuen; Bengt Glimelius; Tormod Guren; Flemming Hansen; Eva Hofsli; Tone Ikdahl; Anders Johnsson; Nina Keldsen; Elin H Kure; Per Pfeiffer; Seppo Pyrhonen; Fridbjorn Sigurdsson; Eva Skovlund; Halfdan Sorbye; Hans Starkhammar; Thoralf Christoffersen
Phase III trial of cetuximab with continuous or intermittent fluorouracil, leucovorin, and oxaliplatin (Nordic FLOX) versus FLOX alone in first-line treatment of metastatic colorectal cancer: the NORDIC-VII study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012;30(15):1755-62.
2012: M P Myklebust; Arne Skarstein; O Fluge; L Balteskard; Ove Bruland; heike immervoll; Olav Dahl
Expression of DSG1 and DSC1 are prognostic markers in anal carcinoma patients.
British journal of cancer 2012;106(4):756-62.
2012: Olav Dahl; Marianne Brydøy
Testicular germ cell tumours - still many challenges.
Acta oncologica (Stockholm, Sweden) 2012;51(2):147-50.
2012: Anneke M Westermann; Curt Burger; Olav Dahl; Ronald De Wit; Ellen L Jones; Peter Koper; Olav Mella; Leonard R Prosnitz; Baard-Christian Schem; Apollonia L J Uitterhoeve; Elzbieta Van Der Steen-Banasik; Jacobus van der Velden; Cl Van Der Wilt; Jacoba van der Zee; Harm van Tinteren
Long-term survival data of triple modality treatment of stage IIB-III-IVA cervical cancer with the combination of radiotherapy, chemotherapy and hyperthermia - an update.
International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group 2012;28(6):549-53.
2011: O Fluge; Ove Bruland; Olav Dahl; Einar K Kristoffersen; Halvor Naess; Harald Nyland; Kristin Risa; Dipak Sapkota; Anette Storstein; Olav Mella
Benefit from B-lymphocyte depletion using the anti-CD20 antibody rituximab in chronic fatigue syndrome. A double-blind and placebo-controlled study.
PloS one 2011;6(10):e26358.
2010: Hege S Haugnes; Torgeir Wethal; Nina Aass; Olav Dahl; Olbjørn Klepp; Carl W Langberg; Tom Wilsgaard; Roy M Bremnes; Sophie D Fosså
Cardiovascular risk factors and morbidity in long-term survivors of testicular cancer: a 20-year follow-up study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(30):4649-57.
2010: Marianne Brydøy; Sophie D Fosså; Olbjørn Klepp; Roy M Bremnes; Erik Wist; Tore Wentzel-Larsen; Olav Dahl
Paternity and testicular function among testicular cancer survivors treated with two to four cycles of cisplatin-based chemotherapy.
European urology 2010;58(1):134-40.
2010: Kjersti Bruheim; Marianne Grønlie Guren; Eva Skovlund; Marianne J Hjermstad; Olav Dahl; Gunilla Frykholm; Erik Carlsen; Kjell Magne Tveit
Late side effects and quality of life after radiotherapy for rectal cancer.
International journal of radiation oncology, biology, physics 2010;76(4):1005-11.
2009: Marianne Brydøy; Jan Oldenburg; Olbjørn Klepp; Roy M Bremnes; Erik Wist; Tore Wentzel-Larsen; Erik R Hauge; Olav Dahl; Sophie D Fosså
Observational study of prevalence of long-term Raynaud-like phenomena and neurological side effects in testicular cancer survivors.
Journal of the National Cancer Institute 2009;101(24):1682-95.
2009: Erling Dahl Borkamo; Baard-Christian Schem; Øystein Fluge; Ove Bruland; Olav Dahl; Olav Mella
cDNA microarray analysis of serially sampled cervical cancer specimens from patients treated with thermochemoradiotherapy.
International journal of radiation oncology, biology, physics 2009;75(5):1562-9.
2009: H K Sigurdsson; Hartwig Kørner; Olav Dahl; Arne Skarstein; Jon Arne Søreide
Rectal cancer with macroscopic peritoneal involvement--clinical challenges and consequences.
Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland 2009;11(8):838-44.
2009: Jørgen Krohn; T Frøystein; Olav Dahl
Topographical distribution of choroidal naevi in the ocular fundus.
Eye (London, England) 2009;23(8):1685-90.
2009: Hege S Haugnes; Nina Aass; Sophie D Fosså; Olav Dahl; Marianne Brydøy; Ulf Aasebø; Tom Wilsgaard; Roy M Bremnes
Pulmonary function in long-term survivors of testicular cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(17):2779-86.
2009: Erling Dahl Borkamo; Olav Dahl; Ove Bruland; Øystein Fluge
Kinetics study on markers of the immune system by gene expression profiling of an in vivo heated tumor.
International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group 2009;25(1):41-6.
2009: Asa Karlsdottir; Ludvig Paul Muren; Tore Wentzel-Larsen; Dag Clement Johannessen; Svein A Haukaas; Ole Johan Halvorsen; Olav Dahl
Outcome in intermediate or high risk prostate cancer patients receiving radiation dose and hormone therapy.
Acta oncologica (Stockholm, Sweden) 2009;48(6):874-81.
2009: Ellen Karine Grov; Sophie D Fosså; Roy M Bremnes; Olav Dahl; Olbjørn Klepp; Erik Wist; Alv A Dahl
The personality trait of neuroticism is strongly associated with long-term morbidity in testicular cancer survivors.
Acta oncologica (Stockholm, Sweden) 2009;48(6):842-9.
2009: Helgi Kjartan Sigurdsson; Jon Arne Søreide; Olav Dahl; Arne Skarstein; Sebastian Von Hofacker; Hartwig Kørner
Utilisation of specialist care in patients with incurable rectal cancer. a population-based study from Western Norway.
Acta oncologica (Stockholm, Sweden) 2009;48(3):377-84.
2009: Olav Dahl; Øystein Fluge; Erik Carlsen; Johan N Wiig; Helge E Myrvold; Barthold Vonen; Nina Podhorny; Ottar Bjerkeset; Tor Jack Eide; Tore B Halvorsen; Kjell Magne Tveit
Final results of a randomised phase III study on adjuvant chemotherapy with 5 FU and levamisol in colon and rectum cancer stage II and III by the Norwegian Gastrointestinal Cancer Group.
Acta oncologica (Stockholm, Sweden) 2009;48(3):368-76.
2008: Jørgen Krohn; Odd R Monge; T N Skorpen; Sverre Mørk; Olav Dahl
Posterior uveal melanoma treated with I-125 brachytherapy or primary enucleation.
Eye (London, England) 2008;22(11):1398-403.
2008: H S Haugnes; N Aass; Sophie D Fosså; Olav Dahl; Olbjørn Klepp; Erik Wist; Tom Wilsgaard; R M Bremnes
Predicted cardiovascular mortality and reported cardiovascular morbidity in testicular cancer survivors.
Journal of cancer survivorship : research and practice 2008;2(3):128-37.
2008: Olav Dahl
2008 ESHO-BSD Award Winner--Gerard C. van Rhoon.
International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group 2008;24(5):444-5.
2008: Erling Dahl Borkamo; Olav Dahl; Ove Bruland; O Fluge
Global gene expression analyses reveal changes in biological processes after hyperthermia in a rat glioma model.
International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group 2008;24(5):425-41.
2008: Ove Bruland; O Fluge; heike immervoll; L Balteskard; Mp Myklebust; Arne Skarstein; Olav Dahl
Gene expression reveals two distinct groups of anal carcinomas with clinical implications.
British journal of cancer 2008;98(7):1264-73.
2008: Ingrid J Orre; Sophie D Fosså; Robert Murison; Roy Bremnes; Olav Dahl; Olbjørn Klepp; Jon H Loge; Erik Wist; Alv A Dahl
Chronic cancer-related fatigue in long-term survivors of testicular cancer.
Journal of psychosomatic research 2008;64(4):363-71.
2008: Asa Karlsdóttir; Ludvig Paul Muren; Tore Wentzel-Larsen; Olav Dahl
Late gastrointestinal morbidity after three-dimensional conformal radiation therapy for prostate cancer fades with time in contrast to genitourinary morbidity.
International journal of radiation oncology, biology, physics 2008;70(5):1478-86.
2008: Erling Dahl Borkamo; O Fluge; Olav Mella; Lars A Akslen; Ove Bruland; Olav Dahl
Hyperthermia improves the antitumour effect of metronomic cyclophosphamide in a rat transplantable brain tumour.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2008;86(3):435-42.
2008: Olav Dahl; Erling Dahl Borkamo; O Fluge
Current status of antivascular therapy and targeted treatment in the clinic.
International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group 2008;24(1):97-110.
2007: Alv A Dahl; Roy M Bremnes; Olav Dahl; Olbjørn Klepp; Erik Wist; Sophie D Fosså
Is the sexual function compromised in long-term testicular cancer survivors?
European urology 2007;52(5):1438-47.
2007: Marianne Brydøy; Anette Storstein; Olav Dahl
Transient neurological adverse effects following low dose radiation therapy for early stage testicular seminoma.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2007;82(2):137-44.
2007: H S Haugnes; N Aass; Sophie D Fosså; Olav Dahl; Olbjørn Klepp; Erik Wist; Johan Svartberg; Tom Wilsgaard; Roy M Bremnes
Components of the metabolic syndrome in long-term survivors of testicular cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2007;18(2):241-8.
2007: Halfdan Sørbye; Ake Berglund; Kjell Magne Tveit; Dagfinn Ogreid; Eva Hoff Wanderås; Tore Wentzel-Larsen; Olav Dahl; Bengt Glimelius
Secondary treatment and predictive factors for second-line chemotherapy after first-line oxaliplatin-based therapy in metastatic colorectal cancer.
Acta oncologica (Stockholm, Sweden) 2007;46(7):982-8.
2007: Annette Larsen; Benedikte Bjørge; Beate Klementsen; Lars Helgeland; Tore Wentzel-Larsen; Magne Kristoffer Fagerhol; Nils Hovdenak; Olav Dahl
Time patterns of changes in biomarkers, symptoms and histopathology during pelvic radiotherapy.
Acta oncologica (Stockholm, Sweden) 2007;46(5):639-50.
2007: Marianne Brydøy; Sophie D Fosså; Olav Dahl; Trine Bjøro
Gonadal dysfunction and fertility problems in cancer survivors.
Acta oncologica (Stockholm, Sweden) 2007;46(4):480-9.
2006: Ludvig Paul Muren; Anthony Thomas Redpath; Duncan McLaren; Jarle Rørvik; Ole Johan Halvorsen; Jens Høstmark; August Bakke; David Thwaites; Olav Dahl
A concomitant tumour boost in bladder irradiation: patient suitability and the potential of intensity-modulated radiotherapy.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2006;80(1):98-105.
2006: Asa Karlsdottir; Paul Ludvig Muren; Tore Wentzel-Larsen; Dag Clement Johannessen; August Bakke; Per Ogreid; Ole Johan Halvorsen; Olav Dahl
Radiation dose escalation combined with hormone therapy improves outcome in localised prostate cancer.
Acta oncologica (Stockholm, Sweden) 2006;45(4):454-62.
2005: Marianne Brydøy; Sophie D Fosså; Olbjørn Klepp; Roy M Bremnes; Erik Wist; Tore Wentzel-Larsen; Olav Dahl
Paternity following treatment for testicular cancer.
Journal of the National Cancer Institute 2005;97(21):1580-8.
2005: Nils Hovdenak; Halfdan Sørbye; Olav Dahl
Sucralfate does not ameliorate acute radiation proctitis: randomised study and meta-analysis.
Clinical oncology (Royal College of Radiologists (Great Britain)) 2005;17(6):485-91.
2005: Anneke M Westermann; Ellen Jones; Baard-Christian Schem; Elzbieta M Van der Steen-Banasik; Peter Koper; Olav Mella; Apollonia L J Uitterhoeve; Ronald de Wit; Jacobus van der Velden; Curt Burger; Clasina L Van der Wilt; Olav Dahl; Leonard R Prosnitz; Jacoba van der Zee
First results of triple-modality treatment combining radiotherapy, chemotherapy, and hyperthermia for the treatment of patients with stage IIB, III, and IVA cervical carcinoma.
Cancer 2005;104(4):763-70.
2005: H Sagstuen; N Aass; Sophie D Fosså; Olav Dahl; Olbjørn Klepp; Erik Wist; Tom Wilsgaard; Roy M Bremnes
Blood pressure and body mass index in long-term survivors of testicular cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(22):4980-90.
2005: Lene Thorsen; Wenche Nystad; Hein Stigum; Olav Dahl; Olbjørn Klepp; Roy M Bremnes; Erik Wist; Sophie D Fosså
The association between self-reported physical activity and prevalence of depression and anxiety disorder in long-term survivors of testicular cancer and men in a general population sample.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2005;13(8):637-46.
2005: Ludvig Paul Muren; Asa Karlsdottir; Yngve Kvinnsland; Tore Wentzel-Larsen; Olav Dahl
Testing the new ICRU 62 'Planning Organ at Risk Volume' concept for the rectum.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2005;75(3):293-302.
2005: Arnstein Mykletun; Alv A Dahl; Carl Fredrik Haaland; Roy M Bremnes; Olav Dahl; Olbjørn Klepp; Erik Wist; Sophie D Fosså
Side effects and cancer-related stress determine quality of life in long-term survivors of testicular cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(13):3061-8.
2005: Alv A Dahl; Carl Fredrik Haaland; Arnstein Mykletun; Roy M Bremnes; Olav Dahl; Olbjørn Klepp; Erik Wist; Sophie D Fosså
Study of anxiety disorder and depression in long-term survivors of testicular cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(10):2389-95.
2004: Ludvig Paul Muren; Rune Smaaland; Olav Dahl
Conformal radiotherapy of urinary bladder cancer.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2004;73(3):387-98.
2004: Annette Larsen; Nils Hovdenak; Asa Karlsdottir; Tore Wentzel-Larsen; Olav Dahl; Magne Kristoffer Fagerhol
Faecal calprotectin and lactoferrin as markers of acute radiation proctitis: a pilot study of eight stool markers.
Scandinavian journal of gastroenterology 2004;39(11):1113-8.
2004: Hans Petter Eikesdal; Olav Dahl; Oddbjørn Straume; Lars A Akslen
[Tumour angiogenesis and therapy directed at the neovasculature].
Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række 2004;124(15):1919-22.
2004: Yngve Kvinnsland; Ludvig Paul Muren; Olav Dahl
A Monte Carlo study of the impact of the choice of rectum volume definition on estimates of equivalent uniform doses and the volume parameter.
Physics in medicine and biology 2004;49(15):3341-52.
2004: Asa Karlsdóttir; Dag Clement Johannessen; Ludvig Paul Muren; Tore Wentzel-Larsen; Olav Dahl
Acute morbidity related to treatment volume during 3D-conformal radiation therapy for prostate cancer.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2004;71(1):43-53.
2004: Halfdan Sørbye; Olav Dahl
Transient CEA increase at start of oxaliplatin combination therapy for metastatic colorectal cancer.
Acta oncologica (Stockholm, Sweden) 2004;43(5):495-8.
2004: Yngve Kvinnsland; Ludvig Paul Muren; Olav Dahl
Evaluation of a new method for calculation of cumulative doses in the rectum wall using repeat CT scans.
Acta oncologica (Stockholm, Sweden) 2004;43(4):388-95.
2004: Ludvig Paul Muren; Randi Ekerold; Yngve Kvinnsland; Asa Karlsdottir; Olav Dahl
On the use of margins for geometrical uncertainties around the rectum in radiotherapy planning.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2004;70(1):11-9.
2004: Halfdan Sørbye; Bengt Glimelius; Ake Berglund; Tone Fokstuen; Kjell Magne Tveit; Morten Braendengen; Dagfinn Øgreid; Olav Dahl
Multicenter phase II study of Nordic fluorouracil and folinic acid bolus schedule combined with oxaliplatin as first-line treatment of metastatic colorectal cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(1):31-8.
2003: Halfdan Sørbye; Olav Dahl
Carcinoembryonic antigen surge in metastatic colorectal cancer patients responding to oxaliplatin combination chemotherapy: implications for tumor marker monitoring and guidelines.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(23):4466-7.
2003: Ludvig Paul Muren; Rune Smaaland; Olav Dahl
Organ motion, set-up variation and treatment margins in radical radiotherapy of urinary bladder cancer.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2003;69(3):291-304.
2003: Carina Nord; Trine Bjøro; Dag Ellingsen; Arnstein Mykletun; Olav Dahl; Olbjørn Klepp; Roy M Bremnes; Erik Wist; Sophie D Fosså
Gonadal hormones in long-term survivors 10 years after treatment for unilateral testicular cancer.
European urology 2003;44(3):322-8.
2003: Inger Norderhaug; Olav Dahl; Per A Høisaeter; Reino Heikkilä; Olbjørn Klepp; Dag Rune Olsen; Ivar Sønbø Kristiansen; Håkon Waehre; Truls E Bjerklund Johansen
Brachytherapy for prostate cancer: a systematic review of clinical and cost effectiveness.
European urology 2003;44(1):40-6.
2003: Halfdan Sørbye; Olav Dahl
Nordic 5-fluorouracil/leucovorin bolus schedule combined with oxaliplatin (Nordic FLOX) as first-line treatment of metastatic colorectal cancer.
Acta oncologica (Stockholm, Sweden) 2003;42(8):827-31.
2003: Nils Hovdenak; Asa Karlsdottir; Halfdan Sørbye; Olav Dahl
Profiles and time course of acute radiation toxicity symptoms during conformal radiotherapy for cancer of the prostate.
Acta oncologica (Stockholm, Sweden) 2003;42(7):741-8.
2002: Inger Norderhaug; Truls Bjerklund Johansen; Olav Dahl; Per A Høisaeter; Reino Heikkilä; Olbjørn Klepp; Dag Rune Olsen; Ivar Sønbø Kristiansen; Håkon Waehre
[Brachytherapy in prostatic cancer].
Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række 2002;122(29):2795-8.
2002: Hans Petter Eikesdal; Willy Landuyt; Olav Dahl
The influence of combretastatin A-4 and vinblastine on interstitial fluid pressure in BT4An rat gliomas.
Cancer letters 2002;178(2):209-17.
2002: Hans Petter Eikesdal; S T Bjorkhaug; Olav Dahl
Hyperthermia exhibits anti-vascular activity in the s.c. BT4An rat glioma: lack of interaction with the angiogenesis inhibitor batimastat.
International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group 2002;18(2):141-52.
2002: Ludvig Paul Muren; Gjertrud Maurstad; Rune Hafslund; Gun Anker; Olav Dahl
Cardiac and pulmonary doses and complication probabilities in standard and conformal tangential irradiation in conservative management of breast cancer.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2002;62(2):173-83.
2002: Ludvig Paul Muren; Olav Mella; Rune Hafslund; Olav Dahl
Norwegian oncologists' expectations of intensity-modulated radiotherapy.
Acta oncologica (Stockholm, Sweden) 2002;41(6):562-5.
2002: Olav Dahl; Olav Mella
Referee: hyperthermia alone or combined with cisplatin in addition to radiotherapy for advanced uterine cervical cancer.
International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group 2002;18(1):25-30.
2001: Hans Petter Eikesdal; R Bjerkvig; James Raleigh; Olav Mella; Olav Dahl
Tumor vasculature is targeted by the combination of combretastatin A-4 and hyperthermia.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2001;61(3):313-20.
2001: S Knutsen; Rune Hafslund; Odd R Monge; H Valen; Ludvig Paul Muren; B L Rekstad; Jørgen Krohn; Olav Dahl
Dosimetric verification of a dedicated 3D treatment planning system for episcleral plaque therapy.
International journal of radiation oncology, biology, physics 2001;51(4):1159-66.
2001: Hans Petter Eikesdal; Rolf Bjerkvig; Olav Dahl
Vinblastine and hyperthermia target the neovasculature in BT(4)AN rat gliomas: therapeutic implications of the vascular phenotype.
International journal of radiation oncology, biology, physics 2001;51(2):535-44.
2001: Hans Petter Eikesdal; R Bjerkvig; Olav Mella; Olav Dahl
Combretastatin A-4 and hyperthermia;a potent combination for the treatment of solid tumors.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2001;60(2):147-54.
2001: Ludvig Paul Muren; N Jebsen; Anders Gustafsson; Olav Dahl
Can dose-response models predict reliable normal tissue complication probabilities in radical radiotherapy of urinary bladder cancer? The impact of alternative radiation tolerance models and parameters.
International journal of radiation oncology, biology, physics 2001;50(3):627-37.
2001: Ludvig Paul Muren; Rune Hafslund; Anders Gustafsson; Rune Smaaland; Olav Dahl
Partially wedged beams improve radiotherapy treatment of urinary bladder cancer.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2001;59(1):21-30.
2001: Halfdan Sørbye; Y Bruserud; Olav Dahl
Oxaliplatin-induced haematological emergency with an immediate severe thrombocytopenia and haemolysis.
Acta oncologica (Stockholm, Sweden) 2001;40(7):882-3.
2000: Ludvig Paul Muren; Rune Hafslund; A Murman; H Valen; Olav Dahl
Partially wedged radiation beams.
Medical physics 2000;27(3):527-34.
2000: Hans Petter Eikesdal; Baard-Christian Schem; Olav Mella; Olav Dahl
The new tubulin-inhibitor combretastatin A-4 enhances thermal damage in the BT4An rat glioma.
International journal of radiation oncology, biology, physics 2000;46(3):645-52.
2000: Ludvig Paul Muren; Rune Hafslund; H Valen; G Schuster; Olav Dahl
Adapting the waterproof BMS-96 diode array for isodose determination of dynamic beams.
Medical dosimetry : official journal of the American Association of Medical Dosimetrists 2000;25(2):87-91.
1999: Olav Dahl; R Dalene; Baard-Christian Schem; Olav Mella
Status of clinical hyperthermia.
Acta oncologica (Stockholm, Sweden) 1999;38(7):863-73.
1998: Halfdan Sørbye; D Jensen; Olav Dahl
Lymphocele after retroperitoneal surgery for testicular or extragonadal germ cell tumors may mimic recurrence.
Urology 1998;51(5):833-4.
1997: S N Hornsleth; L Frydendal; Olav Mella; Olav Dahl; P Raskmark
Quality assurance for radiofrequency regional hyperthermia.
International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group 1997;13(2):169-85.
1997: Peer Lilleng; Odd R Monge; A Walloe; Clement S Trovik; M Hordvik; J Høie; Olav Dahl; G Bang
Fibrosarcoma in children--a rare tumour with long-term survival even with advanced disease--a report of 3 cases.
Acta oncologica (Stockholm, Sweden) 1997;36(4):438-40.